ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
about
Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis.Psoriasis care: new and emerging pharmacologic trends.A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.Voclosporin as a treatment for noninfectious uveitis.Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
P2860
ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2008
@uk
name
ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
@en
ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
@nl
type
label
ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
@en
ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
@nl
prefLabel
ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
@en
ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
@nl
P2093
P2860
P921
P356
P1476
ISA247: quality of life results from a phase II, randomized, placebo-controlled study
@en
P2093
Charles Lynde
Gilles Lauzon
Kirk Barber
Launa J Aspeslet
Randall W Yatscoff
Richard G Langley
Robert T Foster
Wayne Gulliver
P2860
P304
P356
10.2310/7750.2008.07060
P577
2008-11-01T00:00:00Z